200 related articles for article (PubMed ID: 38365726)
41. Hypermethylation of FOXA1 and allelic loss of PTEN drive squamous differentiation and promote heterogeneity in bladder cancer.
Osei-Amponsa V; Buckwalter JM; Shuman L; Zheng Z; Yamashita H; Walter V; Wildermuth T; Ellis-Mohl J; Liu C; Warrick JI; Shantz LM; Feehan RP; Al-Ahmadie H; Mendelsohn C; Raman JD; Kaestner KH; Wu XR; DeGraff DJ
Oncogene; 2020 Feb; 39(6):1302-1317. PubMed ID: 31636388
[TBL] [Abstract][Full Text] [Related]
42. Structural or functional defects of PTEN in urothelial cells lacking P53 drive basal/squamous-subtype muscle-invasive bladder cancer.
He F; Zhang F; Liao Y; Tang MS; Wu XR
Cancer Lett; 2022 Dec; 550():215924. PubMed ID: 36195293
[TBL] [Abstract][Full Text] [Related]
43. LncRNA SNHG1 regulates immune escape of renal cell carcinoma by targeting miR-129-3p to activate STAT3 and PD-L1.
Tian P; Wei JX; Li J; Ren JK; Yang JJ
Cell Biol Int; 2021 Jul; 45(7):1546-1560. PubMed ID: 33739543
[TBL] [Abstract][Full Text] [Related]
44. lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer.
Qiu F; Zhang MR; Zhou Z; Pu JX; Zhao XJ
J Cell Biochem; 2019 Jun; 120(6):10821-10829. PubMed ID: 30672010
[TBL] [Abstract][Full Text] [Related]
45. Long Noncoding RNA Small Nucleolar RNA Host Gene 1 (SNHG1) Promotes Renal Cell Carcinoma Progression and Metastasis by Negatively Regulating miR-137.
Zhao S; Wang Y; Luo M; Cui W; Zhou X; Miao L
Med Sci Monit; 2018 Jun; 24():3824-3831. PubMed ID: 29874202
[TBL] [Abstract][Full Text] [Related]
46. Decreased tumorigenesis and mortality from bladder cancer in mice lacking urothelial androgen receptor.
Hsu JW; Hsu I; Xu D; Miyamoto H; Liang L; Wu XR; Shyr CR; Chang C
Am J Pathol; 2013 May; 182(5):1811-20. PubMed ID: 23499463
[TBL] [Abstract][Full Text] [Related]
47. LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis.
Ge P; Cao L; Zheng M; Yao Y; Wang W; Chen X
Exp Mol Pathol; 2021 Jun; 120():104633. PubMed ID: 33753110
[TBL] [Abstract][Full Text] [Related]
48. LncRNA-p21 inhibited the proliferation of osteosarcoma cells via the miR-130b/PTEN/AKT signaling pathway.
Han W; Liu J
Biomed Pharmacother; 2018 Jan; 97():911-918. PubMed ID: 29136769
[TBL] [Abstract][Full Text] [Related]
49. Rak functions as a tumor suppressor by regulating PTEN protein stability and function.
Yim EK; Peng G; Dai H; Hu R; Li K; Lu Y; Mills GB; Meric-Bernstam F; Hennessy BT; Craven RJ; Lin SY
Cancer Cell; 2009 Apr; 15(4):304-14. PubMed ID: 19345329
[TBL] [Abstract][Full Text] [Related]
50. Transgelin, a p53 and PTEN-Upregulated Gene, Inhibits the Cell Proliferation and Invasion of Human Bladder Carcinoma Cells in Vitro and in Vivo.
Tsui KH; Lin YH; Chang KS; Hou CP; Chen PJ; Feng TH; Juang HH
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31591355
[TBL] [Abstract][Full Text] [Related]
51. LncRNA IGFBP4-1 promotes tumor development by activating Janus kinase-signal transducer and activator of transcription pathway in bladder urothelial carcinoma.
Li C; Cao Y; Zhang L; Li J; Wu H; Ling F; Zheng J; Wang J; Li B; He J; Xie X; Li Z; Chen Y; He X; Guo M; Wei H; Ye J; Guo Y; Zhang S; Liu L; Liu G; Liu C
Int J Biol Sci; 2020; 16(13):2271-2282. PubMed ID: 32760196
[TBL] [Abstract][Full Text] [Related]
52. Long noncoding RNA SNHG1 predicts a poor prognosis and promotes hepatocellular carcinoma tumorigenesis.
Zhang M; Wang W; Li T; Yu X; Zhu Y; Ding F; Li D; Yang T
Biomed Pharmacother; 2016 May; 80():73-79. PubMed ID: 27133041
[TBL] [Abstract][Full Text] [Related]
53. Long non-coding RNA SNHG1 stimulates ovarian cancer progression by modulating expression of miR-454 and ZEB1.
Wu Y; Zhu B; Yan Y; Bai S; Kang H; Zhang J; Ma W; Gao Y; Hui B; Li R; Zhang X; Ren J
Mol Oncol; 2021 May; 15(5):1584-1596. PubMed ID: 33641229
[TBL] [Abstract][Full Text] [Related]
54. Prothymosin-α enhances phosphatase and tensin homolog expression and binds with tripartite motif-containing protein 21 to regulate Kelch-like ECH-associated protein 1/nuclear factor erythroid 2-related factor 2 signaling in human bladder cancer.
Tsai YS; Jou YC; Tsai HT; Shiau AL; Wu CL; Tzai TS
Cancer Sci; 2019 Apr; 110(4):1208-1219. PubMed ID: 30719818
[TBL] [Abstract][Full Text] [Related]
55. Lnc-MUC20-9 binds to ROCK1 and functions as a tumor suppressor in bladder cancer.
Dai R; Zhou Y; Chen Z; Zou Z; Pan Z; Liu P; Gao X
J Cell Biochem; 2020 Oct; 121(10):4214-4225. PubMed ID: 31898364
[TBL] [Abstract][Full Text] [Related]
56. LncRNA LINC00641 predicts prognosis and inhibits bladder cancer progression through miR-197-3p/KLF10/PTEN/PI3K/AKT cascade.
Li Z; Hong S; Liu Z
Biochem Biophys Res Commun; 2018 Sep; 503(3):1825-1829. PubMed ID: 30060954
[TBL] [Abstract][Full Text] [Related]
57. β-Catenin activation synergizes with PTEN loss to cause bladder cancer formation.
Ahmad I; Morton JP; Singh LB; Radulescu SM; Ridgway RA; Patel S; Woodgett J; Winton DJ; Taketo MM; Wu XR; Leung HY; Sansom OJ
Oncogene; 2011 Jan; 30(2):178-89. PubMed ID: 20818428
[TBL] [Abstract][Full Text] [Related]
58. LncRNA SNHG1 promotes tumor progression and cisplatin resistance through epigenetically silencing miR-381 in breast cancer.
Zhang M; Yang L; Hou L; Tang X
Bioengineered; 2021 Dec; 12(2):9239-9250. PubMed ID: 34806925
[TBL] [Abstract][Full Text] [Related]
59. Transformation of human urothelial cells (UROtsa) by as and cd induces the expression of keratin 6a.
Somji S; Bathula CS; Zhou XD; Sens MA; Sens DA; Garrett SH
Environ Health Perspect; 2008 Apr; 116(4):434-40. PubMed ID: 18414623
[TBL] [Abstract][Full Text] [Related]
60. lncRNA OIP5-AS1 Suppresses Cell Proliferation and Invasion of Endometrial Cancer by Regulating PTEN/AKT via Sponging miR-200c-3p.
Liu Y; Cai X; Cai Y; Chang Y
J Immunol Res; 2021; 2021():4861749. PubMed ID: 34368370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]